#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4651342	A	Mean oral bioavailability in Swiss albino male mice at 2.5 mg/kg per compound (administered in a mixture of 5 compounds to 3 mice) assessed by LCMS/MS.	Mus musculus	52		organism-based format	Salvensis and LSHTM Schistosomiasis screening data
2.	ALA4651343	A	Mean AUC inf in Swiss albino male mice at 1 mg/kg per compound (administered iv in a mixture of 5 compounds to 3 mice) assessed by LCMS/MS.	Mus musculus	55		organism-based format	Salvensis and LSHTM Schistosomiasis screening data
3.	ALA4651344	A	Mean observed clearance in Swiss albino male mice at 1 mg/kg per compound (administered iv in a mixture of 5 compounds to 3 mice) assessed by LCMS/MS.	Mus musculus	55		organism-based format	Salvensis and LSHTM Schistosomiasis screening data
4.	ALA4651345	A	Mean volume of distribution at steady state in Swiss albino male mice at 1 mg/kg per compound (administered iv in a mixture of 5 compounds to 3 mice) assessed by LCMS/MS.	Mus musculus	55		organism-based format	Salvensis and LSHTM Schistosomiasis screening data
5.	ALA4651346	A	Mean half-life in Swiss albino male mice at 1 mg/kg per compound (administered iv in a mixture of 5 compounds to 3 mice) assessed by LCMS/MS.	Mus musculus	55		organism-based format	Salvensis and LSHTM Schistosomiasis screening data
6.	ALA4651347	A	Mean plasma concentration at 24h in Swiss albino male mice at 2.5 mg/kg per compound (administered orally in a mixture of 5 compounds to 3 mice) assessed by LCMS/MS.	Mus musculus	55		organism-based format	Salvensis and LSHTM Schistosomiasis screening data
7.	ALA4651348	A	Mean plasma concentration at 4h in Swiss albino male mice at 2.5 mg/kg per compound (administered orally in a mixture of 5 compounds to 3 mice) assessed by LCMS/MS.	Mus musculus	55		organism-based format	Salvensis and LSHTM Schistosomiasis screening data
8.	ALA4651349	A	Mean time to peak plasma concentration in Swiss albino male mice at 2.5 mg/kg per compound (administered orally in a mixture of 5 compounds to 3 mice) assessed by LCMS/MS.	Mus musculus	53		organism-based format	Salvensis and LSHTM Schistosomiasis screening data
9.	ALA4651351	A	Percentage of parent compound remaining after incubation for 90 minutes with cyropreserved human hepatocytes at a concentration of 1uM compound and 1 million cells/uL, determined by LCMS/MS	Homo sapiens	15		tissue-based format	Salvensis and LSHTM Schistosomiasis screening data
10.	ALA4651352	A	Plasma protein binding determined at 10uM by LC-MS/MS.	Homo sapiens	13		cell-free format	Salvensis and LSHTM Schistosomiasis screening data
11.	ALA4651354	P	Partition coefficient of compound between n-octanol and PBS (pH7.4)		38		small-molecule physicochemical format	Salvensis and LSHTM Schistosomiasis screening data
12.	ALA4651356	A	Percentage of parent compound remaining after incubation for 90 minutes with cyropreserved mouse hepatocytes at a concentration of 1uM compound and 0.5 million cells/uL, determined by LCMS	Mus musculus	42		tissue-based format	Salvensis and LSHTM Schistosomiasis screening data
13.	ALA4651357	A	Plasma protein binding determined at 10uM by LC-MS/MS.	Mus musculus	26		cell-free format	Salvensis and LSHTM Schistosomiasis screening data
14.	ALA4651359	P	Solubility at 25 degC of compound (diluted from DMSO) in FaSSIF at pH 6.5 (2.24 g/l of SIF powder [Na-taurocholate: 3.0mM, Lecithin:0.75mM, Pancreatin:10mg/ml], 0.42 g/l of NaOH, 4.4 g/l NaH₂PO₄ monobasic dihydrate, 6.19 g/l NaCl) determined after 24h (1h sonication, 22h shaking, 1h sonication) by LCMS/MS		7		small-molecule physicochemical format	Salvensis and LSHTM Schistosomiasis screening data
15.	ALA4651360	P	Solubility at 25 degC of compound (diluted from DMSO) in FeSSIF at pH 5.0 (11.2 g/l of SIF powder [Na-taurocholate: 15.0mM, Lecithin:3.75mM, Pancreatin:40mg/ml], 4.04 g/l of NaOH, 8.65 g/l Glacial Acetic Acid, 11.87 g/l NaCl) determined after 24h (1h sonication, 22h shaking, 1h sonication) by LCMS/MS		7		small-molecule physicochemical format	Salvensis and LSHTM Schistosomiasis screening data
16.	ALA4651361	P	Solubility at 25 degC of compound (diluted from DMSO) in PBS at pH 7.4 determined after 24h (1h sonication, 22h shaking, 1h sonication) by LCMS/MS		60		small-molecule physicochemical format	Salvensis and LSHTM Schistosomiasis screening data
17.	ALA4651362	F	Concentration required to kill 50% of 84 day old worms 5 days after drug treatment.	Schistosoma haematobium	10		organism-based format	Salvensis and LSHTM Schistosomiasis screening data
18.	ALA4651363	F	Concentration required to kill 50% of 42 day old worms 5 days after drug treatment.	Schistosoma japonicum	8		organism-based format	Salvensis and LSHTM Schistosomiasis screening data
19.	ALA4651364	F	Concentration required to kill 50% of 42 day old worms 5 days after drug treatment.	Schistosoma mansoni	98		organism-based format	Salvensis and LSHTM Schistosomiasis screening data
20.	ALA4651365	F	Concentration required to kill 50% of 21 day old worms 5 days after drug treatment.	Schistosoma mansoni	262		organism-based format	Salvensis and LSHTM Schistosomiasis screening data